The city of Oxnard, California, currently has 1 active clinical trials seeking participants for Lung Cancer research studies.
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC
Recruiting
The main purpose of the study is to evaluate safety and efficacy of taletrectinib (also known as AB-106 or DS-6051b) monotherapy in the treatment of advanced NSCLC.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/14/2024
Locations: PMK Medical Group Inc, Oxnard, California
Conditions: Non Small Cell Lung Cancer